Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.040 AUD
−61.43 M AUD
0.00 AUD
1.43 B
About Immutep Ltd
Sector
Industry
CEO
Marc Voigt
Website
Headquarters
Sydney
Founded
1987
ISIN
AU000000IMM6
FIGI
BBG000BLY887
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IMM is 0.250 AUD — it hasn't changed in the past 24 hours. Watch Immutep Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Immutep Ltd stocks are traded under the ticker IMM.
IMM stock has risen by 4.17% compared to the previous week, the month change is a −3.85% fall, over the last year Immutep Ltd has showed a −28.57% decrease.
We've gathered analysts' opinions on Immutep Ltd future price: according to them, IMM price has a max estimate of 2.10 AUD and a min estimate of 0.46 AUD. Watch IMM chart and read a more detailed Immutep Ltd stock forecast: see what analysts think of Immutep Ltd and suggest that you do with its stocks.
IMM stock is 2.00% volatile and has beta coefficient of 1.53. Track Immutep Ltd stock price on the chart and check out the list of the most volatile stocks — is Immutep Ltd there?
Today Immutep Ltd has the market capitalization of 366.96 M, it has increased by 2.08% over the last week.
Yes, you can track Immutep Ltd financials in yearly and quarterly reports right on TradingView.
Immutep Ltd is going to release the next earnings report on Feb 19, 2026. Keep track of upcoming events with our Earnings Calendar.
IMM earnings for the last half-year are −0.03 AUD per share, whereas the estimation was −0.03 AUD, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.02 AUD per share. See more details about Immutep Ltd earnings.
Immutep Ltd revenue for the last half-year amounts to 900.00 K AUD, despite the estimated figure of 0.00 AUD. In the next half-year revenue is expected to reach 1.55 M AUD.
IMM net income for the last half-year is −39.06 M AUD, while the previous report showed −22.38 M AUD of net income which accounts for −74.54% change. Track more Immutep Ltd financial stats to get the full picture.
No, IMM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Immutep Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Immutep Ltd technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Immutep Ltd stock shows the sell signal. See more of Immutep Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.